Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 11 - 20 of 22 results
-
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP SA02 as an Adjunct to Best Available Antibiotic Therapy Compared to Best Available Antibiotic Therapy Alone for the Treatment of Adults With Bacteremia Due to Staphylococcus aureus
Date:
08/16/2022Topics:
Lead Investigators:
-
Regimens with omadacycline (OMC) for treatment of Mycobacteroides abscessus disease
Date:
11/01/2021Lead Investigators:
-
Preclinical Program for Targeting Myobacterium tuberculosis KasA
Date:
08/10/2021Topics:
Lead Investigators:
-
Harnessing potent next-generation diarylquinolines for long-acting injectable formulations to prevent and treat tuberculosis (Assist # 830011)
Date:
06/25/2021Topics:
Lead Investigators:
-
Reference strains of Mycobacteroides abscessus
Date:
04/01/2021Lead Investigators:
-
A strategy for new regimens to treat pulmonary Mycobacteroides abscessus infection
Date:
09/15/2020Lead Investigators:
-
The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)
Date:
07/16/2020Lead Investigators:
-
Evaluating the role of L, D-transpeptidases in mycobacterial pathogenesis
Date:
06/18/2020Lead Investigators:
-
Foam cells as drug targets in tuberculosis
Date:
08/01/2019Topics:
Lead Investigators:
-
LONG acting pipeline to Establish therapies for malaria, tuberculosis and hepatitis C Virus with Infrastructure for sustainable Translational capacitY (LONGEVITY)
Date:
07/26/2019Lead Investigators: